Vanda Pharmaceuticals (VNDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Sales | 4,548 | 0 | 0 | 0 | 0 |
| Cost of Goods | 1,915 | N/A | N/A | N/A | N/A |
| Gross Profit | 2,633 | N/A | N/A | N/A | N/A |
| Operating Expenses | 39,496 | 52,845 | 80,038 | 65,708 | 24,287 |
| Operating Income | -35,948 | -52,845 | -80,038 | -65,708 | -24,287 |
| Interest Expense | 0 | 0 | 0 | 5 | 26 |
| Other Income | 89 | 1,781 | 5,979 | 2,203 | 436 |
| Pre-tax Income | -35,859 | -51,064 | -74,060 | -63,511 | -23,877 |
| Income Tax | N/A | N/A | 10 | 1 | 8 |
| Net Income Continuous | -35,859 | -51,064 | -74,070 | -63,511 | -23,884 |
| Net Income | $-35,859 | $-51,064 | $-74,070 | $-63,511 | $-23,884 |
| EPS Basic Total Ops | -1.33 | -1.92 | -2.81 | -3.97 | -3,374.33 |
| EPS Basic Continuous Ops | -1.33 | -1.92 | -2.81 | -3.97 | -1,404.96 |
| EPS Diluted Total Ops | -1.33 | -1.92 | -2.81 | -3.97 | -3,374.33 |
| EPS Diluted Continuous Ops | -1.33 | -1.92 | -2.81 | -3.97 | -1,404.96 |
| EBITDA(a) | $-34,385 | $-52,549 | $-81,039 | $-65,133 | $-23,863 |